Contents of this document
- Making バイオ・サイト・キャピタル株式会社 a wholly owned subsidiary
- 2-for-1 stock split of common shares
- Expansion of shareholder benefits
- Introduction of an Executive Officer System
- Adoption of the ¥10 billion declaration
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter (interim period) of the fiscal year ending March 2027 |
| Net Sales | 1,942 Millions of yen (YoY +83.8%) |
| Operating profit | 10 Millions of yen (YoY -22.9%) |
| Ordinary income | -50 Millions of yen |
| Net income | ¥-33 million (interim net income attributable to owners of the parent) |
| Gross Profit Margin | 20.4 % |
| Selling, general and administrative expenses | 386 Millions of yen |
| Full-year earnings forecast | Net Sales 2,300 Millions of yen / Operating profit 300 Millions of yen / Ordinary income 230 Millions of yen / Profit attributable to owners of the parent 200 Millions of yen / Earnings per share 24.32 Yen |
| Progress against full-year forecast | Net Sales 84.4 / Operating profit 3.5 / Ordinary income Not disclosed / Profit attributable to owners of the parent Not disclosed |
| Segment results | Oil Net Sales 820 Millions of yen (YoY -8.1%) / Segment profit 44 Millions of yen (YoY -7.5%) / Real Estate Business Net Sales 1,118 Millions of yen / Segment profit 146 Millions of yen (YoY +142.2%) / Fund business Net Sales 3 Millions of yen / Segment profit -27 Millions of yen / Specialty retail business Not disclosed |
| Breakdown of Factors Affecting the Change | Net Sales Not disclosed / Operating profit Oil -3 / Real Estate Business 85 / Specialty retail business 15 / Fund business -27 / Company-wide expenses (adjustments) -73 / From operating income to interim net loss Operating profit 10 / Non-operating income 6 / Interest expenses -43 / Fees paid -21 / Other non-operating expenses -2 / Ordinary loss -50 / Income Taxes 17 / Interim net loss -33 |
| Financial targets | Equity ratio 25.6 % |
| Annual Dividend | 10 Yen per share |
| Capital expenditures | ¥4 million (acquisitions of property, plant and equipment) |
| New initiatives | Making バイオ・サイト・キャピタル株式会社 a wholly owned subsidiary, 2-for-1 stock split of common shares, Expansion of shareholder benefits, Introduction of an Executive Officer System, Adoption of the ¥10 billion declaration |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to the sale of 4 properties held for sale that were acquired in the previous fiscal year. SG&A expenses increased due to growth investments, including costs for establishing systems associated with the transition to consolidated financial reporting and the expansion of shareholder benefits. The ordinary loss was attributed to one-off factors such as borrowing fees incurred when acquiring the properties and changes in accounting expense items.